- CAPITAL MARKETS DAY: “SHAPING (NEW) MARKETS”, FEATURING PRESENTATIONS ON PANOMICS, IPSC & A.I./M.L. PLATFORMS FOR GROWTH AND ACCELERATED PIPELINE BUILDING
- VIDEO RECORDING OF ON-SITE EVENT AT EVOTEC’S HEADQUARTERS, MANFRED EIGEN CAMPUS IN HAMBURG, GERMANY, ON 15 NOVEMBER 2023 NOW AVAILABLE
Hamburg, Germany, 16 November 2023:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announces that a video recording of the Capital Markets Day presentations is now available via this link.
Evotec’s second Capital Markets Day in 2023 was held on 15 November as an on-site event at the Company’s headquarters, Manfred Eigen Campus in Hamburg, Germany. Evotec’s Management and senior scientific staff illustrated how the Company is driving more efficient pipeline building towards assets, that are progressing with higher probabilities of success. Evotec’s platforms leverage novel A.I.-powered technologies that lead to new opportunities, higher capital efficiency, and ultimately improved patient outcomes and commercial success.
The Capital Markets Day featured the following presentations:
- Welcome Message
Dr Claudia Karnbach, EVP, Global Head of Partnering, Site Head Hamburg
- Shaping new Markets: from disease understanding to pipeline building
Dr Werner Lanthaler, Chief Executive Officer
- PanOmics: from patients for patients
Dr Cord Dohrmann, Chief Scientific Officer
- E.MPD: pipeline building starts with better disease understanding
Dr Olivier Radresa, SVP, Head of Nephrology
- EVOgnostics: better pipeline building needs better patient stratification
Dr Christiane Honisch, SVP, Head of Diagnostics
- iPSC: Better pipeline building needs advanced disease modelling
Dr Sandra Lubitz, SVP, iPSC
- Efficient pipeline building accelerating with A.I.
Prof. Dr Bhushan Bonde, Head of Innovation for In-silico R&D
- Integrated platform for iPSC-based Therapeutics
Dr Christine Günther, EVP, Head of Global Cell Therapy Translation
Dr Andreas Scheel, EVP, Head of Cell Therapy
Dr Markus Dangl, EVP, Head of Innovate Oncology
Evotec’s next Capital Markets Day will take place on 10 October 2024 at the Company’s Toulouse site “Campus Curie”, where the J.POD Toulouse, France (EU) is currently under construction.